HIGHLIGHTS
- who: Miao Liu and colleagues from the College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China have published the research work: Investigation of the Underlying Mechanism of Huangqi- Dangshen for Myasthenia Gravis Treatment via Molecular Docking and Network Pharmacology, in the Journal: Evidence-Based Complementary and Alternative Medicine of 28/07/2022
- what: Trough network pharmacology the fndings in this study provide light on the coordinated action of several HD formula components targets and pathways.
- how: Trough further analysis the results showed that the active compounds from HD (such as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.